Eric J. Gowans

Eric J. Gowans

Auto-generated profile, based on publicly available information

Eric J. Gowans

Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
BGBranka Grubor-Bauk
Branka Grubor-Bauk
DWD. K. Wijesundara
D. K. Wijesundara
MMM. Masavuli
M. Masavuli
PAP. Abbink
P. Abbink
RPR. L. Peterson
R. L. Peterson
EGE. J. Gowans
E. J. Gowans
A novel T cell–based ZIKV vaccine, encoding NS1 protein, confers protection against systemic infection.

15 March 2008 in Journal of Virology
Verified
Journal Article
Open access
PDF file
DWDavid J. Woollard
David J. Woollard
GHGholamreza Haqshenas
Gholamreza Haqshenas
XDXuebin Dong
Xuebin Dong
BPBridget F. Pratt
Bridget F. Pratt
SKStephen J. Kent
Stephen J. Kent
EGEric J. Gowans
Eric J. Gowans
GB virus B (GBV-B) is a hepatotropic virus that is closely related to hepatitis C virus (HCV). GBV-B causes acute hepatitis in infected marmosets and tamarins and is therefore a useful small-animal model for the study of HCV. We investigated virus-specific T-cell responses in marmosets infected with GBV-B. Gamma interferon (IFN-γ) enzyme-linked immunospot (ELISPOT) assay responses in the peripheral blood of two marmosets were assessed throughout the course of GBV-B infection. These T-cell responses were directed against the GBV-B nonstructural proteins 3 (NS3), 4A (NS4A), and 5B (NS5B), and their appearance was temporally associated with clearance of viremia. These marmosets were then rechallenged with GBV-B at least 3 months after clearance of the primary infection to determine if the animals were protected from reinfection. There was no detectable viremia following reinfection, although a sharp increase in T-cell responses against GBV-B proteins was observed. Epitope mapping of T-cell responses to GBV-B was performed with liver and blood samples from both marmosets after rechallenge with GBV-B. Three shared, immunodominant T-cell epitopes within NS3 were identified in animals with multiple common major histocompatibility complex class I alleles. IFN-γ ELISPOT responses were also detected in the livers of two marmosets that had resolved a primary GBV-B infection. These responses were high in frequency and were directed against epitopes within GBV-B NS3, NS4A, and NS5B proteins. These results indicate that virus-specific T-cell responses are detectable in the liver and blood of GBV-B-infected marmosets and that the clearance of GBV-B is associated with the appearance of these responses.

1 September 1998 in Transfusion
Verified
Journal Article
Closed access
PDF file
CHC. A. Hyland
C. A. Hyland
LML. Mison
L. Mison
NSN. Solomon
N. Solomon
JCJ. Cockerill
J. Cockerill
LWLijuan Wang
Lijuan Wang
EGE. J. Gowans
E. J. Gowans


5 September 2013 in Protocol Exchange
Verified
Journal Article
Open access
SLShuo Li
Shuo Li
Marie-Paule LefrancMarie-Paule Lefranc
Marie-Paule Lefranc
EGEric Gowans
Eric Gowans
VGVéronique Giudicelli
Véronique Giudicelli
We describe a workflow combing 5’RACE PCR, 454 sequencing and IMGT/HighV-QUEST for profiling human T cell receptor repertoire.

1 January 2006 in Journal of Clinical Virology
Verified
Journal Article
Closed access
Y. Rebecca ChinY. Rebecca Chin
Y. Rebecca Chin
BKB. Koeberlein
B. Koeberlein
HZH. Zengtraf
H. Zengtraf
EGE. Gowans
E. Gowans
C.-Thomas BockC.-Thomas Bock
C.-Thomas Bock
Joseph TorresiJoseph Torresi
Joseph Torresi